Dalhousie University Researchers, DeNovaMed Inc. Develop New Family of Antibiotics That Could Treat Multidrug Resistant Bacterial 'Superbugs'

HALIFAX, Nova Scotia, Nov. 29 (TNSres) -- Dalhousie University issued the following news release:

For the first time in over 30 years, researchers at Dalhousie University, DeNovaMed Inc. and the University of Toronto have developed a new family of antibiotics to treat multidrug-resistant bacteria, addressing a concern the World Health Organization has identified as one of the three greatest threats to human health.

Antimicrobial medicines are the cornerstone of modern m . . .

To gain access to full content fill out the form below.

Information Request Form

I'd like more information
Sign me up for a free trial

Name:
Newspaper/Company:
Email:
Phone:
State:
Keywords or Areas of Interest:

Select Product(s) you are interested in:
Daily Federal Tipoffs for your City/State
Congressional Vote Chart
Federal Contract Awards
Federal Patent Awards
News Releases from Federal Agencies
News Releases from States
News Releases from Counties
News Releases from Cities
Golf Handicap site (FairwayFiles.com)

Filling out this form will generate a contact, by phone or e-mail, from a TNS editor. No automated information is provided. How would you like to be contacted: Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Alison Auld, Senior Research Reporter, 902/220-0491, alison.auld@dal.ca